VIR BIOTECHNOLOGY INC

GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treatment of COVID-19

26 Mar 2021 08:30:40 By Nasdaq GlobeNewswire

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19

10 Mar 2021 20:22:03 By Nasdaq GlobeNewswire

Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19

03 Mar 2021 09:00:01 By Nasdaq GlobeNewswire

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

25 Feb 2021 16:01:01 By Nasdaq GlobeNewswire

GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses

17 Feb 2021 07:04:31 By Nasdaq GlobeNewswire

Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

11 Feb 2021 16:01:00 By Nasdaq GlobeNewswire

Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the Development of Therapeutics

01 Feb 2021 08:00:01 By Nasdaq GlobeNewswire

Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19

27 Jan 2021 06:45:00 By Nasdaq GlobeNewswire

Initial Data from Ongoing Phase 1 Trial of VIR-3434 for Chronic Hepatitis B Virus Infection Demonstrates Significant and Rapid Reduction in Hepatitis B Surface Antigen

26 Jan 2021 08:00:01 By Nasdaq GlobeNewswire

Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus

12 Jan 2021 08:00:02 By Nasdaq GlobeNewswire

Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19

12 Jan 2021 03:00:00 By Nasdaq GlobeNewswire

Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform

06 Jan 2021 08:00:02 By Nasdaq GlobeNewswire

Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference

05 Jan 2021 08:00:01 By Nasdaq GlobeNewswire